FDA Approval Activities for this Drug…

EVOXAC (cevimeline HCl) Capsules, 30 mg, SnowBrand NDA 20-989 1/11/00 1/19/00 1/19/00 3/12/02 EVOXAC Indication: for the treatment of symptoms of dry mouth in patients with Sjogren's Syndrome.

For the latest approval information, please locate this drug using this index.